| Name | Title | Contact Details |
|---|
intra-op monitoring services is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Covington, LA. To find more information about intra-op monitoring services, please visit www.iomservices.com
The Hospital for Sick Children (SickKids) is recognized as one of the world’s foremost paediatric health-care institutions and is Canada’s leading centre dedicated to advancing children’s health through the integration of patient care, research and education. Founded in 1875 and affiliated with the University of Toronto, SickKids is one of Canada’s most research-intensive hospitals and has generated discoveries that have helped children globally. Our mission is to provide the best in complex and specialized family-centred care; pioneer scientific and clinical advancements; share expertise; foster an academic environment that nurtures health-care professionals; and champion an accessible, comprehensive and sustainable child health system. SickKids is proud of its vision of Healthier Children. A Better World.
Dental One Partners is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Cleveland, OH. To find more information about Dental One Partners, please visit www.dentalonepartners.com
Halfpenny Technologies, Inc. provides clinical labs, hospitals, accountable care organizations (ACOs), health plans, health information exchanges (HIEs) and EHR vendors with a cloud-based, secure, scalable and vendor-neutral clinical data exchange platform designed to optimize patient care coordination while reducing waste. We have a long-standing, proven track record of providing advanced features, rapid implementation, reliable technology infrastructure and LOINC mapping that enables laboratories and hospitals to win new accounts and improve service to existing clients
ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.